AR037908A1 - Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus - Google Patents
Una biomasa en particulas de embrion aviar para la produccion de antigenos de virusInfo
- Publication number
- AR037908A1 AR037908A1 ARP020104953A ARP020104953A AR037908A1 AR 037908 A1 AR037908 A1 AR 037908A1 AR P020104953 A ARP020104953 A AR P020104953A AR P020104953 A ARP020104953 A AR P020104953A AR 037908 A1 AR037908 A1 AR 037908A1
- Authority
- AR
- Argentina
- Prior art keywords
- biomass
- production
- virus antigens
- avian embryo
- embryo particles
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 3
- 239000002028 Biomass Substances 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 210000001161 mammalian embryo Anatomy 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000271566 Aves Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se proporciona una biomasa que comprende partículas de embrión aviar que tienen un tamano de partícula de aproximadamente 0,5 mm a 10,0 mm y el uso de la misma en un método para la producción de antígenos de virus. También proporciona un método para la preparación de una vacuna útil para el mejoramiento y prevención de enfermedades virales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34333901P | 2001-12-21 | 2001-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR037908A1 true AR037908A1 (es) | 2004-12-22 |
Family
ID=23345706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020104953A AR037908A1 (es) | 2001-12-21 | 2002-12-18 | Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus |
Country Status (18)
Country | Link |
---|---|
US (3) | US20040023358A1 (es) |
EP (2) | EP1458851A1 (es) |
JP (1) | JP2005514018A (es) |
KR (1) | KR20040070250A (es) |
CN (1) | CN100408675C (es) |
AR (1) | AR037908A1 (es) |
AU (1) | AU2002360659B2 (es) |
BR (1) | BR0215013A (es) |
CA (1) | CA2471131A1 (es) |
CO (1) | CO5590972A2 (es) |
HR (1) | HRP20040641A2 (es) |
HU (1) | HU225995B1 (es) |
MX (1) | MXPA04005888A (es) |
NZ (1) | NZ534070A (es) |
PL (1) | PL371381A1 (es) |
RS (1) | RS55404A (es) |
TW (1) | TWI267553B (es) |
WO (1) | WO2003055988A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8237946B2 (en) * | 2004-10-08 | 2012-08-07 | Sharp Laboratories Of America, Inc. | Methods and systems for imaging device accounting server redundancy |
US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH638985A5 (de) * | 1979-04-10 | 1983-10-31 | Schweiz Serum & Impfinst | Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff. |
AT393277B (de) * | 1990-01-04 | 1991-09-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
MX9700170A (es) * | 1994-06-20 | 1997-04-30 | Los Estados Unidos De America | Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite. |
US5698433A (en) * | 1994-11-10 | 1997-12-16 | Immuno Ag | Method for producing influenza virus and vaccine |
JP3490536B2 (ja) * | 1995-04-21 | 2004-01-26 | 株式会社ブリヂストン | 空気入りラジアルタイヤ |
US5672485A (en) * | 1996-08-13 | 1997-09-30 | Regents Of The University Of Minnesota | Immortalized cell lines for virus growth |
-
2002
- 2002-12-04 US US10/309,658 patent/US20040023358A1/en not_active Abandoned
- 2002-12-13 TW TW091136088A patent/TWI267553B/zh not_active IP Right Cessation
- 2002-12-18 KR KR10-2004-7009611A patent/KR20040070250A/ko not_active Application Discontinuation
- 2002-12-18 EP EP02795935A patent/EP1458851A1/en not_active Withdrawn
- 2002-12-18 CA CA002471131A patent/CA2471131A1/en not_active Abandoned
- 2002-12-18 CN CNB028253124A patent/CN100408675C/zh not_active Expired - Fee Related
- 2002-12-18 RS YU55404A patent/RS55404A/sr unknown
- 2002-12-18 EP EP09005619A patent/EP2157173A1/en not_active Withdrawn
- 2002-12-18 AR ARP020104953A patent/AR037908A1/es unknown
- 2002-12-18 AU AU2002360659A patent/AU2002360659B2/en not_active Ceased
- 2002-12-18 WO PCT/US2002/040567 patent/WO2003055988A1/en active IP Right Grant
- 2002-12-18 MX MXPA04005888A patent/MXPA04005888A/es not_active Application Discontinuation
- 2002-12-18 BR BR0215013-1A patent/BR0215013A/pt not_active IP Right Cessation
- 2002-12-18 PL PL02371381A patent/PL371381A1/xx not_active Application Discontinuation
- 2002-12-18 NZ NZ534070A patent/NZ534070A/en not_active IP Right Cessation
- 2002-12-18 HU HU0402548A patent/HU225995B1/hu not_active IP Right Cessation
- 2002-12-18 JP JP2003556508A patent/JP2005514018A/ja active Pending
-
2004
- 2004-06-16 CO CO04056261A patent/CO5590972A2/es not_active Application Discontinuation
- 2004-07-13 HR HR20040641A patent/HRP20040641A2/hr not_active Application Discontinuation
-
2005
- 2005-12-28 US US11/320,355 patent/US20080102507A1/en not_active Abandoned
-
2009
- 2009-05-20 US US12/469,351 patent/US20090226487A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090226487A1 (en) | 2009-09-10 |
TW200301305A (en) | 2003-07-01 |
CN100408675C (zh) | 2008-08-06 |
AU2002360659A1 (en) | 2003-07-15 |
EP1458851A1 (en) | 2004-09-22 |
CN1604961A (zh) | 2005-04-06 |
PL371381A1 (en) | 2005-06-13 |
HU225995B1 (en) | 2008-02-28 |
HRP20040641A2 (en) | 2004-10-31 |
US20040023358A1 (en) | 2004-02-05 |
US20080102507A1 (en) | 2008-05-01 |
CA2471131A1 (en) | 2003-07-10 |
EP2157173A1 (en) | 2010-02-24 |
RS55404A (en) | 2006-10-27 |
TWI267553B (en) | 2006-12-01 |
CO5590972A2 (es) | 2005-12-30 |
BR0215013A (pt) | 2004-11-09 |
NZ534070A (en) | 2006-01-27 |
WO2003055988A1 (en) | 2003-07-10 |
HUP0402548A2 (hu) | 2005-03-29 |
KR20040070250A (ko) | 2004-08-06 |
MXPA04005888A (es) | 2004-09-13 |
AU2002360659B2 (en) | 2009-01-08 |
JP2005514018A (ja) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60121136D1 (de) | Proteasom-influenzavirus-impfstoffzusammensetzung | |
EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
CY1112572T1 (el) | Εμβολια γριπης που περιλαμβανουν συνδυασμους σωματιδιακων ανοσοενισχυτικων και ανοσοδιεγερτες | |
ECSP045300A (es) | Antígenos virales | |
CY1108789T1 (el) | Καθαρισμος αντιγονων hbv για χρηση σε εμβολια | |
CO5540349A2 (es) | Preparacion vacunal de virus de influenza inactivado | |
AR032597A1 (es) | Uso de antigenos del virus de la gripe inactivado, en la preparacion de vacunas de una sola dosis intranasal; metodo para la profilaxis de enfermedades o de infecciones gripales en pacientes; equipos que comprenden dichas vacunas en dosis unicas y metodo para fabricar vacunas para la gripe para apli | |
AU2003246373A1 (en) | Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
AR042530A1 (es) | Vacuna que comprende particulas viroides del virus papiloma humano 16 y 18 | |
AR004464A1 (es) | Un metodo para producir una proteina de capside de papilomavirus | |
ATE455124T1 (de) | Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber | |
AR037908A1 (es) | Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus | |
CL2010001175A1 (es) | Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv). | |
PT833903E (pt) | Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino | |
ATE471990T1 (de) | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln | |
AR023534A1 (es) | Vacuna. | |
WO2003032917A3 (en) | Hookworm vaccine | |
ES2165109T3 (es) | Vacuna mejorada para la inmunizacion contra infecciones por el virus de la tbe y procedimiento para su preparacion. | |
AR016987A1 (es) | Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a | |
UY31574A1 (es) | Vacunas contra la malaria | |
CL2004000282A1 (es) | Composicion de vacuna que comprende un nodavirus de peces inactivado, procedimiento de preparacion de la composicion, uso para la produccion de un medicamento para prevenir o tratar una infeccion por nodavirus en peces. | |
WO2003050135A3 (en) | Use a parapox b2l protein to modify immune responses to administered antigens | |
DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
AR011592A1 (es) | Metodo de creacion, o mantenimiento o para inducir una inmuno respuesta protectora o adaptativa a un virus hiv en un huesped |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |